Skip to Content

Clopidogrel

In the US, Clopidogrel (clopidogrel systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Acute Coronary Syndrome, Acute Coronary Syndrome - Prophylaxis, Heart Attack, Ischemic Stroke, Ischemic Stroke - Prophylaxis, Percutaneous Coronary Intervention, Peripheral Arterial Disease, Platelet Aggregation Inhibition and Transient Ischemic Attack.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AC04

CAS registry number (Chemical Abstracts Service)

0113665-84-2

Chemical Formula

C16-H16-Cl-N-O2-S

Molecular Weight

321

Therapeutic Category

Antiplatelet agent inhibiting adenosine diphosphate-mediated platelet aggregation

Chemical Name

tieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, metyl ester, (S)-

Foreign Names

  • Clopidogrelum (Latin)
  • Clopidogrel (German)
  • Clopidogrel (French)
  • Clopidogrel (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

(web1)